PharmaResearch Co., Ltd. (KOSDAQ:214450)
434,500
-5,500 (-1.25%)
Nov 12, 2025, 3:30 PM KST
PharmaResearch Revenue
PharmaResearch had revenue of 140.61B KRW in the quarter ending June 30, 2025, with 69.19% growth. This brings the company's revenue in the last twelve months to 449.81B, up 51.66% year-over-year. In the year 2024, PharmaResearch had annual revenue of 350.12B with 34.14% growth.
Revenue (ttm)
449.81B
Revenue Growth
+51.66%
P/S Ratio
10.16
Revenue / Employee
999.58M
Employees
450
Market Cap
4.57T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 350.12B | 89.10B | 34.14% |
| Dec 31, 2023 | 261.01B | 66.25B | 34.02% |
| Dec 31, 2022 | 194.76B | 40.68B | 26.40% |
| Dec 31, 2021 | 154.08B | 45.34B | 41.69% |
| Dec 31, 2020 | 108.75B | 24.87B | 29.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.50T |
| SK Biopharmaceuticals | 620.28B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |